ClinicalTrials.Veeva

Menu

Fitness and Lung Function Among Survivors of Heart Transplant, Leukemia and Infant BPD Through Exercise (FLASHLITE)

University of Minnesota (UMN) logo

University of Minnesota (UMN)

Status

Enrolling

Conditions

Chronic Lung Disease
Chronic Obstructive Pulmonary Disease
Acute Lymphoblastic Leukemia
Heart Transplant

Treatments

Other: Physical activity

Study type

Observational

Funder types

Other

Identifiers

NCT05025774
PEDS-2021-29482

Details and patient eligibility

About

This study aims to more accurately assess cardiac function, ventilation and exercise capacity in a non-invasive fashion, and to better characterize exercise intolerance in the setting of three populations of individuals with chronic diseases of childhood (acute lymphoblastic leukemia (ALL), chronic lung disease (CLD) of prematurity, and post-heart transplant (HT))

Full description

Physical activity in childhood is an integral part of maintaining health and quality of life. Children who participate in routine physical activity are more likely to maintain a healthy body weight and are less likely to have heart disease, type 2 diabetes and high blood pressure as adults. Children with chronic disease are often limited from full participation in exercise for various reasons -perceived physical limitations, either from the patient and family or from their medical provider, or because of symptoms which cause exercise to feel uncomfortable. As the number of children living and aging with chronic disease continues to grow, the researchers are hoping to expand the current exercise testing capabilities for both clinical care and research in order to (i) provide data to permit formulation of evidence-based guidelines for exercise in chronic childhood disease; (ii) improve understanding of limitations to exercise in this growing population; (iii) learn long-term implications of chronic childhood disease as these individuals enter adulthood.

Enrollment

90 estimated patients

Sex

All

Ages

8 to 25 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Cases:

    • Acute lymphoblastic leukemia survivor, OR living with chronic lung disease of prematurity, OR living with heart transplant
    • 8-25 years old
    • Height: ≥ 48 inches
    • Ambulatory without assistance
    • English speaking
    • Normotensive (<95th percentile for age; okay if managed with antihypertensive medication)
    • SpO2 >92%
    • Not pregnant
    • ALL survivor specific: must have completed therapy ≥ 3 months prior to study entry
  • Controls

    • 8-25 years old
    • Height: ≥ 48 inches
    • Ambulatory without assistance
    • English speaking
    • No history of arrhythmia or known cardiac dysfunction at baseline
    • Normotensive (<95th percentile for age; okay if managed with antihypertensive medication)
    • SpO2 >95%
    • Not pregnant

Exclusion criteria

  • Cases:

    • ALL specific: received cranial radiation, bone marrow transplant recipients
    • Investigator or patient's primary physician deems the patient unsuitable for the study
  • Controls:

    • History of malignancy, CLD or HT or any other diagnosis which may reduce cardiorespiratory function
    • Investigator deems the patient unsuitable for the study

Trial design

90 participants in 2 patient groups

Case
Description:
Adolescent or young adult acute lymphoblastic leukemia survivor, OR living with chronic lung disease of prematurity, OR living with heart transplant
Treatment:
Other: Physical activity
Control
Description:
14-25 years old healthy individuals who are ambulatory without assistance. We may enroll younger subjects but we wish to subjects to match our patient population
Treatment:
Other: Physical activity

Trial contacts and locations

1

Loading...

Central trial contact

Pianosi Paolo, MD; Char Napurski, MPH, CCRP

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems